Jaguar Health plans Neonorm Dog launch via Amazon, Chewy

• Jaguar Health unveiled Neonorm Dog, extending its Neonorm franchise into the companion animal market to broaden revenue opportunities.
• Planned distribution via Amazon and Chewy targets scaled e-commerce reach, accelerating brand awareness beyond existing foal and calf products.
• Survey data signaled strong adoption potential: 90% of 33 veterinary oncologists saw clinical relevance; 94% of 18 dog owners indicated purchase intent.
• Positioning centers on non-antibiotic digestive support, aiming to differentiate in a crowded pet GI category and support repeat, at-home use.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.